Bio-Rad Laboratories | BIO - رأس المال والاحتياطيات





رأس المال والاحتياطيات تغيير تاريخ
Abbott USD 52.06B 69M 2026-03
Agilent USD 7.12B 214M 2026-03
Becton, Dickinson and Co. USD 24.13B 1.15B 2026-03
Bio Techne USD 2.09B 74.32M 2026-03
Bio-Rad Laboratories USD 6.85B 602.3M 2026-03
Bruker USD 2.46B 35.9M 2025-12
Charles River Laboratories USD 2.9B 265.94M 2026-03
Danaher USD 52.95B 415M 2026-03
General Electric Aerospace USD 18.06B 841M 2026-03
Illumina USD 2.68B 47M 2026-03
IQVIA Holdings USD 6.22B 282M 2026-03
Laboratory Of America USD 8.73B 108.8M 2026-03
Merck USD 45.88B 6.73B 2026-03
Mettler Toledo International USD -41.88M 18.25M 2026-03
Myriad Genetics USD 337.4M 30.6M 2026-03
OraSure Technologies USD 313.32M 27.5M 2026-03
Pacific Biosciences Of California USD 2.37M 2.98M 2026-03
Quest Diagnostics USD 7.37B 196M 2026-03
Repligen USD 2.11B 666K 2026-03
Revvity USD 7.25B 125.54M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Siemens EUR 64.39B 1.09B 2026-03
Standard Biotools USD 561.12M 136.83M 2026-03
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Tosoh JPY 831.79B 28.49B 2026-03
Waters USD 2.56B 230.55M 2025-12